Cripto-1 as a novel therapeutic target for triple negative breast cancer.
Castro NP, Fedorova-Abrams ND, Merchant AS, Rangel MC, Nagaoka T, Karasawa H, Klauzinska M, Hewitt SM, Biswas K, Sharan SK, Salomon DS.
Castro NP, et al.
Oncotarget. 2015 May 20;6(14):11910-29. doi: 10.18632/oncotarget.4182.
Oncotarget. 2015.
PMID: 26059540
Free PMC article.